314 related articles for article (PubMed ID: 20528610)
1. Generation and genetic modification of induced pluripotent stem cells.
Schambach A; Cantz T; Baum C; Cathomen T
Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
[TBL] [Abstract][Full Text] [Related]
2. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
3. Exploiting pluripotency for therapeutic gain.
Deng W
Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
[TBL] [Abstract][Full Text] [Related]
4. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
5. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
Li Y; Geng YJ
Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
[TBL] [Abstract][Full Text] [Related]
6. Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
Liras A
Thromb Res; 2011 Jul; 128(1):8-13. PubMed ID: 21396685
[TBL] [Abstract][Full Text] [Related]
7. Generation of human-induced pluripotent stem cells.
Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
[TBL] [Abstract][Full Text] [Related]
8. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
10. The evolving field of induced pluripotency: recent progress and future challenges.
Sommer CA; Mostoslavsky G
J Cell Physiol; 2013 Feb; 228(2):267-75. PubMed ID: 22767332
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy, gene targeting and induced pluripotent stem cells: applications in monogenic disease treatment.
Wong GK; Chiu AT
Biotechnol Adv; 2011; 29(1):1-10. PubMed ID: 20656005
[TBL] [Abstract][Full Text] [Related]
12. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
13. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
14. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
[TBL] [Abstract][Full Text] [Related]
15. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
[TBL] [Abstract][Full Text] [Related]
16. Generation of parthenogenetic induced pluripotent stem cells from parthenogenetic neural stem cells.
Do JT; Joo JY; Han DW; Araúzo-Bravo MJ; Kim MJ; Greber B; Zaehres H; Sobek-Klocke I; Chung HM; Schöler HR
Stem Cells; 2009 Dec; 27(12):2962-8. PubMed ID: 19816953
[TBL] [Abstract][Full Text] [Related]
17. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
18. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
Shafa M; Krawetz R; Rancourt DE
Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
20. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
